Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients - BCSH and BTS Guidelines-Reference-Cited by-同舟云学术

Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients - BCSH and BTS Guidelines

Published:2010-02-09 Issue:5 Volume:149 Page:693-705
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Parker Anne,Bowles Kristin,Bradley J. Andrew,Emery Vincent,Featherstone Carrie,Gupte Girish,Marcus Robert,Parameshwar Jayan,Ramsay Alan,Newstead Charles,

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2010.08160.x/fullpdf

Reference89 articles.

1. MALToma: a Helicobacter pylori-associated malignancy in transplant patients: a report from the Israel Penn International Transplant Tumor Registry with a review of published literature;Aull;Transplantation,2003

2. Experience with 274 cardiac recipients with posttransplant lymphoproliferative disorder: a report from the Israel Penn International Transplant Tumor Registry;Aull;Transplantation,2004

3. Lymphoproliferative disorders in Oxford renal transplant recipients;Bates;Journal of Clinical Pathology,2003

4. Successful treatment of posttransplant lymphoproliferative disease with prolonged rituximab treatment in intestinal transplant recipients;Berney;Transplantation,2002

5. Long-term follow-up of kidney transplant patients with posttransplant lymphoproliferative disorder: duration of post-transplant lymphoproliferative disorder-induced operational graft tolerance, interleukin-18 course, and results of re-transplantation;Birkeland;Transplantation,2003

Cited by 189 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD);Orphanet Journal of Rare Diseases;2024-08-23

2. Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trial;Blood;2024-07-25

3. The IPTA Nashville consensus conference on post‐transplant lymphoproliferative disorders after solid organ transplantation in children: IV‐consensus guidelines for the management of post‐transplant lymphoproliferative disorders in children and adolescents;Pediatric Transplantation;2024-05-29

4. Management strategies for common viral infections in pediatric renal transplant recipients;World Journal of Transplantation;2024-03-18

5. Transplantation Pathology;MacSween's Pathology of the Liver;2024